激素替代疗法通过抑制气膜骨损失和炎症来缓解牙周炎
Ying Man1, Jianyong Qin1, Hongliang Qiu1
1Department of Stomatology, Shengli Oilfield Central Hospital, Dongying, China.
Oral diseases
|November 6, 2024
概括
激素替代疗法 (HRT) 可以通过减少骨损失和炎症来帮助减少牙周炎. 这项研究研究了HRT的研究.
科学领域:
- 牙周病学 牙周病学
- 内分泌学 在内分泌学.
- 生物材料是一种生物材料.
背景情况:
- 更年期相关的荷尔蒙变化可能会影响口腔健康.
- 激素替代疗法 (HRT) 和牙周炎之间的关系尚不清楚.
- 牙周炎涉及骨损失和牙炎症.
研究的目的:
- 研究HRT对牙周炎的影响,重点关注骨损失和炎症.
- 评估HRT对膜骨高度,厚度和矿物密度的影响.
- 在牙周炎模型中评估HRT对炎症标志物的影响.
主要方法:
- 形束计算断层扫描 (CBCT) 用于测量女性气泡骨参数.
- 用一种鼠类牙周炎模型来评估骨损失和生化标志物.
- 炎症标志物 (TNF-α,IL-1β,IL-6) 被量化以评估牙周炎症.
主要成果:
- 在患者中,HRT显示出较低膜骨高度和厚度的趋势,以及较高的骨矿物质密度.
- 在牙周炎的老鼠模型中,HRT显著降低了膜骨损失.
- 给予HRT显著降低了牙周炎中关键炎症标志物的高水平.
结论:
- HRT在治疗牙周炎方面表现出有益的效果.
- HRT通过减轻膜骨损失,有助于牙周炎缓解.
- HRT有效地抑制与牙周炎相关的炎症.
相关概念视频
Bone Remodeling
38.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.2K
Hormones and Bone Tissue
2.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.6K
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Teeth
327
The formation of teeth, also known as odontogenesis, is a complex process that begins in utero, around the sixth week of embryonic development. There are three stages to this process: the bud stage, the cap stage, and the bell stage.
In the bud stage, the tooth germ (an aggregation of cells) starts to form in the developing jawbone. During the cap stage, the tooth germ differentiates into enamel organ, dental papilla, and dental sac, which will later develop into the tooth's enamel, dentin...
In the bud stage, the tooth germ (an aggregation of cells) starts to form in the developing jawbone. During the cap stage, the tooth germ differentiates into enamel organ, dental papilla, and dental sac, which will later develop into the tooth's enamel, dentin...
327
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
154
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
154


